Acquisition by Geraghty James A of tradable shares of Pieris Pharmaceuticals at 1.0 subject to Rule 16b-3

Slightly above 67% of PIRS Old's investor base is looking to short. The analysis of current outlook of investing in PIRS Old suggests that many traders are alarmed regarding PIRS Old's prospects. PIRS Old's investing sentiment can be driven by a variety of factors including economic data, PIRS Old's earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Pieris Pharmaceuticals Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at investing.com
Investing News at Macroaxis
  
Acquisition of 1 series f preferred stock, par value $0.001 per share at 1.0 of Pieris Pharmaceuticals by Geraghty James A on 28th of October 2024. This event was filed by Pieris Pharmaceuticals with SEC on 2024-08-07. Statement of changes in beneficial ownership - SEC Form 4

PIRS Old Fundamental Analysis

We analyze PIRS Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PIRS Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PIRS Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Outstanding

Shares Outstanding Comparative Analysis

PIRS Old is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

PIRS Old Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with PIRS Old stock to make a market-neutral strategy. Peer analysis of PIRS Old could also be used in its relative valuation, which is a method of valuing PIRS Old by comparing valuation metrics with similar companies.

Peers

PIRS Old Related Equities

ADCTADC Therapeutics   12.58   
0%
100.0%
TERNTerns Pharmaceuticals   3.54   
0%
28.0%
XFORX4 Pharmaceuticals   2.78   
0%
22.0%
INZYInozyme Pharma   2.75   
0%
21.0%
ACHLAchilles Therapeutics   0.72   
5.0%
0%
AFMDAffimed NV   2.00   
15.0%
0%
CRVSCorvus Pharmaceuticals   2.23   
17.0%
0%
CUECue Biopharma   2.50   
19.0%
0%
MREOMereo BioPharma   3.33   
26.0%
0%
ADAPAdaptimmune Therapeutics   5.88   
46.0%
0%
LPTXLeap Therapeutics   8.70   
69.0%
0%
PDSBPDS Biotechnology   9.02   
71.0%
0%
CKPTCheckpoint Therapeutics   10.14   
80.0%
0%
AGENAgenus   10.88   
86.0%
0%
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Consideration for investing in PIRS Stock

If you are still planning to invest in PIRS Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PIRS Old's history and understand the potential risks before investing.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Stocks Directory
Find actively traded stocks across global markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope